{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T15:53:36Z","timestamp":1762271616524},"reference-count":6,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1097\/jcp.0b013e3182549243","type":"journal-article","created":{"date-parts":[[2012,5,4]],"date-time":"2012-05-04T08:58:00Z","timestamp":1336121880000},"page":"428-429","source":"Crossref","is-referenced-by-count":8,"title":["Dopamine Dysregulation Syndrome Including Mania Related to Coadministration of Droxidopa"],"prefix":"10.1097","volume":"32","author":[{"given":"Shinnosuke","family":"Saito","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsutoshi","family":"Shioda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kouichi","family":"Nishijima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R2-26-20210128","first-page":"595","article-title":"Compulsive use of dopamine replacement therapy in Parkinsons disease: reward systems gone awry Lancet Neurol.","volume":"2","author":"Lawrence","year":"2003","journal-title":""},{"key":"R3-26-20210128","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1136\/jnnp.68.4.423","article-title":". Hedonistic dysregulation in patients with Parkinsons disease on dopamine replacement therapies.","volume":"68","author":"Giovannoni","year":"2000","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R4-26-20210128","doi-asserted-by":"crossref","first-page":"157","DOI":"10.2165\/00023210-200923020-00005","article-title":"Dopamine dysregulation syndrome: an overview of its epidemiology, mechanisms and management.","volume":"23","author":"OSullivan","year":"2009","journal-title":"CNS Drugs"},{"key":"R5-26-20210128","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1097\/01.wco.0000137528.23126.41","article-title":"Dopamine dysregulation syndrome in Parkinsons disease.","volume":"17","author":"Evans","year":"2004","journal-title":"Curr Opin Neurol"},{"key":"R6-26-20210128","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0021-5198(19)59576-2","article-title":"Effect of L-threo-dihydroxyphenylserine on the in vivo release of catecholamines, studied by intracerebral dialysis.","volume":"40","author":"Shimoyama","year":"1986","journal-title":"Jpn J Pharmacol"},{"key":"R7-26-20210128","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/BF02252660","article-title":"A new metabolic pathway of L-threo-3,4-dihydroxyphenylserine, a precursor amino acid of norepinephrine, in the brain. Studies by in vivo microdialysis.","volume":"7","author":"Maruyama","year":"1994","journal-title":"J Neural Transm Park Dis Dement Sect"}],"container-title":["Journal of Clinical Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/JCP.0b013e3182549243","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T01:59:55Z","timestamp":1620957595000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00004714-201206000-00026"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":6,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/jcp.0b013e3182549243","relation":{},"ISSN":["0271-0749"],"issn-type":[{"value":"0271-0749","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6]]}}}